LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings
AUM
$11.3B
1-Year Return
14.72%
This Quarter Return
+6.3%
1 Year Return
+14.72%
3 Year Return
+73.17%
5 Year Return
+113.06%
10 Year Return
+348.26%
AUM
$11.2B
AUM Growth
+$342M
(+3.2%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
46.03%
Holding
602
New
51
Increased
94
Reduced
180
Closed
31
Top Buys
| 1 |
Synopsys
SNPS
|
$42.3M |
| 2 |
Veeva Systems
VEEV
|
$24.7M |
| 3 |
Amazon
AMZN
|
$21.3M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$15.2M |
| 5 |
Microsoft
MSFT
|
$13.9M |
Top Sells
| 1 |
Salesforce
CRM
|
$36.1M |
| 2 |
Broadcom
AVGO
|
$34.1M |
| 3 |
Paycom
PAYC
|
$14.3M |
| 4 |
Fiserv
FI
|
$8.33M |
| 5 |
Stryker
SYK
|
$5.59M |
Sector Composition
| 1 | Technology | 39.27% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 10.49% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
SBA Communications
SBAC
$21.2B
| $9.35K | ﹤0.01% |
38
| – | – |
|
502
Moderna
MRNA
$9.78B
| $9.24K | ﹤0.01% |
175
-315
| -64% | -$16.6K |
|
503
Amylyx Pharmaceuticals
AMLX
$910M
| $8.84K | ﹤0.01% |
1,803
| – | – |
|
504
Chemours
CC
$2.34B
| $8.56K | ﹤0.01% |
460
-2,912
| -86% | -$54.2K |
|
|
XYZ
505
Block, Inc.
XYZ
$45.7B
| $7.98K | ﹤0.01% |
110
+10
| +10% | +$726 |
|
506
Fidelity National Information Services
FIS
$35.9B
| $7.86K | ﹤0.01% |
87
-11
| -11% | -$994 |
|
507
Quest Diagnostics
DGX
$20.5B
| $7.58K | ﹤0.01% |
48
-105
| -69% | -$16.6K |
|
508
Pultegroup
PHM
$27.7B
| $7.47K | ﹤0.01% |
+55
| New | +$7.47K |
|
509
DraftKings
DKNG
$23.1B
| $7.36K | ﹤0.01% |
200
| – | – |
|
510
Prologis
PLD
$105B
| $6.98K | ﹤0.01% |
+58
| New | +$6.98K |
|
|
SRCL
511
DELISTED
Stericycle Inc
SRCL
| $6.82K | ﹤0.01% |
112
| – | – |
|
512
Pacira BioSciences
PCRX
$1.19B
| $6.81K | ﹤0.01% |
400
| – | – |
|
513
Medical Properties Trust
MPW
$2.77B
| $6.41K | ﹤0.01% |
1,300
| – | – |
|
514
SolarEdge
SEDG
$2.04B
| $6.33K | ﹤0.01% |
415
| – | – |
|
515
Hexcel
HXL
$5.16B
| $6.28K | ﹤0.01% |
100
| – | – |
|
516
Zions Bancorporation
ZION
$8.34B
| $6.26K | ﹤0.01% |
120
| – | – |
|
517
CME Group
CME
$94.4B
| $6.2K | ﹤0.01% |
+27
| New | +$6.2K |
|
518
Quanta Services
PWR
$55.5B
| $6.2K | ﹤0.01% |
20
| – | – |
|
519
CoStar Group
CSGP
$37.9B
| $5.91K | ﹤0.01% |
80
| – | – |
|
520
Marriott International Class A Common Stock
MAR
$71.9B
| $5.73K | ﹤0.01% |
+22
| New | +$5.73K |
|
521
Darden Restaurants
DRI
$24.5B
| $5.69K | ﹤0.01% |
+35
| New | +$5.69K |
|
522
Novavax
NVAX
$1.28B
| $5.65K | ﹤0.01% |
570
| – | – |
|
523
Oshkosh
OSK
$8.93B
| $5.63K | ﹤0.01% |
+54
| New | +$5.63K |
|
524
Solventum
SOLV
$12.6B
| $5.34K | ﹤0.01% |
73
-133
| -65% | -$9.74K |
|
525
Kraft Heinz
KHC
$32.3B
| $5.26K | ﹤0.01% |
150
-57
| -28% | -$2K |
|